Rexon-Eye uses QMR (quantum molecular resonance) technology to deliver controlled, low-intensity, high-frequency electrical fields that stimulate cellular metabolism without thermal damage.
Clinical studies report up to 45% improvement in tear break-up time and significant reductions in ocular surface disease index (OSDI) scores after a simple treatment protocol of six 20-minute sessions over six weeks.1
According to Eyetek, evidence also indicates enhanced goblet cell density and improved meibomian gland function, supporting restoration of ocular surface homeostasis rather than temporary symptom relief.1
The procedure is non-invasive, well tolerated, and integrates easily into clinical workflow without ongoing consumable costs.
Visit: eyetek.com.au
Reference
- Foo VHX, et al. Front Med (Lausanne). 2023. doi: 10.3389/fmed.2023.1209886.
